Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 55, Issue 7, Pages 3228-3241Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm201683b
Keywords
-
Categories
Funding
- NHS
- Cancer Research UK [C309/A8274, C24461/A10285]
- Wellcome Trust
- Association for International Cancer Research
- Royal Society
- ICR
- Cancer Research UK [11566] Funding Source: researchfish
Ask authors/readers for more resources
We report herein a series of Nek2 inhibitors based on an aminopyridine scaffold. These compounds have been designed by combining key elements of two previously discovered chemical series. Structure based design led to aminopyridine (R)-21, a potent and selective inhibitor able to modulate Nek2 activity in cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available